Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Nephrology"
DOI: 10.1159/000523947
Abstract: Introduction: This study examines factors associated with erythropoiesis-stimulating agent (ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new episodes, and variation across countries. Methods: We used international Dialysis Outcomes and Practice Patterns Study… read more here.
Keywords: erythropoiesis stimulating; patients hemodialysis; resistance; among patients ... See more keywords